Purpose: The effect of total-body irradiation (TBI) on the biodistribution
and pharmacokinetics of In-111-DTPA-labeled pegylated liposomes (IT)LPL) wa
s evaluated in tumor-bearing nude mice as part of an ongoing effort to deve
lop liposome-targeted radiosensitizers, Methods and Materials: Mice receive
d TBI (2 Gy or 5 Gy) according to two protocols: (1) to test the effect of
radiation delivered 30 min before liposome injection on the time course of
IDLPL biodistribution to tumor and normal tissues over 96 h; (2) to test th
e effect of radiation at times ranging from 72 h to 1 h before liposome inj
ection on tumor and normal tissue uptake of IDLPL at 24 h, Tumor and tissue
/organ levels of liposome uptake were measured by dissection and quantitati
on in a gamma counter, Results: For most tissues (tumor, liver, kidney, lun
g, skin, heart, and central nervous system), irradiation did not alter IDLP
L biodistribution, Splenic uptake appeared to be increased by TBI, but furt
her analysis revealed that this effect was due to reduced splenic weight in
irradiated mice. IDLPL uptake was increased in the small intestine, stomac
h, musculoskeletal system, female reproductive tract, and adrenal glands in
irradiated mice. Conclusion: These findings suggest that concomitant admin
istration of liposomal radiosensitizers during radical radiotherapy is like
ly to be safe. However, caution should be exercised in situations in which
significant volumes of small intestine or hemopoietic tissue will be irradi
ated. (C) 2001 Elsevier Science Inc.